Efficacy and safety of novel dipeptidyl-peptidase-4 inhibitor evogliptin in the management of type 2 diabetes mellitus: A meta-analysis
2020 ◽
Vol 24
(5)
◽
pp. 434
2007 ◽
Vol 9
(5)
◽
pp. 733-745
◽
2017 ◽
Vol 9
(4)
◽
pp. 893-902
◽
2013 ◽
Vol 39
(5)
◽
pp. 309-321
2014 ◽
Vol 103
(3)
◽
pp. 395-401
◽
2019 ◽
Vol 32
(7)
◽
pp. 695-702
◽
2019 ◽
Vol Volume 11
◽
pp. 7427-7438
◽
2016 ◽
Vol 116
◽
pp. 86-95
◽